(Approval lapsed) VAXCHORA cholera vaccine (recombinant, live, oral) effervescent powder and powder for oral suspension (UK)
Section 19A approved medicine
(Approval lapsed) VAXCHORA cholera vaccine (recombinant, live, oral) effervescent powder and powder for oral suspension (UK)
Section 19A approval holder
Biocelect Pty Ltd ABN 88 168 092 171
Phone
1300 848 628
Approved until
Status
Expired
Medicines in short supply/unavailable
Vaxchora Vibrio cholerae bacteria cells (CVD 103-HgR strain) 4 x 10^8 to 2 x 10^9 CFU suspension, powder for, sachet - ARTG 389746
Indication(s)
Active immunisation against disease caused by Vibrio cholerae serogroup O1 in adults and children aged 2 years and older travelling to cholera affected countries.
VAXCHORA vaccine should be used in accordance with official recommendations.
The vaccine should not replace standard preventive hygiene measures.
Images
